Terms: = Brain cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras
177 results:
1. Mosaic RASopathies concept: different skin lesions, same systemic manifestations?
Morren MA; Fodstad H; Brems H; Bedoni N; Guenova E; Jacot-Guillarmod M; Busiah K; Giuliano F; Gilliet M; Atallah I
J Med Genet; 2024 Apr; 61(5):411-419. PubMed ID: 38290824
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological Features and Prognosis of Lung Adenocarcinoma Patients With k-ras Gene Mutation.
Sun D; Liu Y; Li P; Yang P; Yu G
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):406-413. PubMed ID: 37338109
[TBL] [Abstract] [Full Text] [Related]
3. Schimmelpenning-Feuerstein-Mims syndrome induced by hras Gly12Ser somatic mosaic mutation: Case report and literature review.
Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
[TBL] [Abstract] [Full Text] [Related]
4. The Use of Liquid Biopsy in the Molecular Analysis of Plasma Compared to the Tumour Tissue from a Patient with brain Metastasis: A Case Report.
Aran V; Zogbi VM; Miranda RL; Andreiuolo F; Silva Canedo NH; Nazaré CV; Niemeyer Filho P; Neto VM
Medicina (Kaunas); 2023 Feb; 59(3):. PubMed ID: 36984460
[TBL] [Abstract] [Full Text] [Related]
5. Discordance of PIK3CA and TP53 mutations between breast cancer brain metastases and matched primary tumors.
Thulin A; Andersson C; Werner Rönnerman E; De Lara S; Chamalidou C; Schoenfeld A; Kovács A; Fagman H; Enlund F; Linderholm BK
Sci Rep; 2021 Dec; 11(1):23548. PubMed ID: 34876602
[TBL] [Abstract] [Full Text] [Related]
6. k-ras Acts as a Critical Regulator of CD44 to Promote the Invasiveness and Stemness of GBM in Response to Ionizing Radiation.
Zhao Y; Kang JH; Yoo KC; Kang SG; Lee HJ; Lee SJ
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681583
[TBL] [Abstract] [Full Text] [Related]
7. Genetic and epigenetic characterization of posterior pituitary tumors.
Schmid S; Solomon DA; Perez E; Thieme A; Kleinschmidt-DeMasters BK; Giannini C; Reinhardt A; Asa SL; Mete O; Stichel D; Siewert C; Dittmayer C; Hasselblatt M; Paulus W; Nagel C; Harter PN; Schittenhelm J; Honegger J; Rushing E; Coras R; Pfister SM; Buslei R; Koch A; Perry A; Jones DTW; von Deimling A; Capper D; Lopes MB
Acta Neuropathol; 2021 Dec; 142(6):1025-1043. PubMed ID: 34661724
[TBL] [Abstract] [Full Text] [Related]
8. Identification of a recurrent mosaic
Green TE; MacGregor D; Carden SM; Harris RV; Hewitt CA; Berkovic SF; Penington AJ; Scheffer IE; Hildebrand MS
Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34649968
[TBL] [Abstract] [Full Text] [Related]
9. Infrequent RAS mutation is not associated with specific histological phenotype in gliomas.
Makino Y; Arakawa Y; Yoshioka E; Shofuda T; Minamiguchi S; Kawauchi T; Tanji M; Kanematsu D; Nonaka M; Okita Y; Kodama Y; Mano M; Hirose T; Mineharu Y; Miyamoto S; Kanemura Y
BMC Cancer; 2021 Sep; 21(1):1025. PubMed ID: 34525976
[TBL] [Abstract] [Full Text] [Related]
10. Identification of mutant k-ras in pituitary macroadenoma.
Aran V; Heringer M; da Mata PJ; Kasuki L; Miranda RL; Andreiuolo F; Chimelli L; Filho PN; Gadelha MR; Neto VM
Pituitary; 2021 Oct; 24(5):746-753. PubMed ID: 33954928
[TBL] [Abstract] [Full Text] [Related]
11. Exploiting the anticancer effects of a nitrogen bisphosphonate nanomedicine for glioblastoma multiforme.
Jena LN; Bennie LA; McErlean EM; Pentlavalli S; Glass K; Burrows JF; Kett VL; Buckley NE; Coulter JA; Dunne NJ; McCarthy HO
J Nanobiotechnology; 2021 May; 19(1):127. PubMed ID: 33947409
[TBL] [Abstract] [Full Text] [Related]
12. The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence.
Rabbie R; Ferguson P; Wong K; Couturier DL; Moran U; Turner C; Emanuel P; Haas K; Saunus JM; Davidson MR; Lakhani SR; Shivalingam B; Long GV; Parkinson C; Osman I; Scolyer RA; Corrie P; Adams DJ
Br J Cancer; 2021 Jan; 124(1):156-160. PubMed ID: 33024263
[TBL] [Abstract] [Full Text] [Related]
13. Familial Cerebral Cavernous Malformation Syndrome with Concomitant Fourth Ventricular Ependymoma: True Association or Mere Coincidence?
Algattas H; Abou-Al-Shaar H; Mendelson M; Arnold GL; Felker J; Meade J; Greene S
Cancer Genet; 2020 Jun; 244():36-39. PubMed ID: 32434131
[TBL] [Abstract] [Full Text] [Related]
14. Dequalinium chloride inhibits the growth of human glioma cells in vitro and vivo: a study on molecular mechanism and potential targeted agents.
Yu Y; Yang B; Yu J; Zhao G; Chen F
Acta Neurochir (Wien); 2020 Jul; 162(7):1683-1690. PubMed ID: 32410120
[TBL] [Abstract] [Full Text] [Related]
15. SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM.
Mukherjee S; Stroberg E; Wang F; Morales L; Shan Y; Rao A; Huang JH; Wu E; Fonkem E
J Neuropathol Exp Neurol; 2020 May; 79(5):562-565. PubMed ID: 32296843
[TBL] [Abstract] [Full Text] [Related]
16. Uptake and tumor-suppressive pathways of exosome-associated GKN1 protein in gastric epithelial cells.
Yoon JH; Ashktorab H; Smoot DT; Nam SW; Hur H; Park WS
Gastric Cancer; 2020 Sep; 23(5):848-862. PubMed ID: 32291710
[TBL] [Abstract] [Full Text] [Related]
17. Case report: recurrent pituitary adenoma has increased load of somatic variants.
Peculis R; Balcere I; Radovica-Spalvina I; Konrade I; Caune O; Megnis K; Rovite V; Stukens J; Nazarovs J; Breiksa A; Kiecis A; Silamikelis I; Pirags V; Klovins J
BMC Endocr Disord; 2020 Jan; 20(1):17. PubMed ID: 31996211
[TBL] [Abstract] [Full Text] [Related]
18. Primary epithelial-myoepithelial carcinoma of the pituitary gland.
Lavin V; Callipo F; Donofrio CA; Ellwood-Thompson R; Metcalf R; Djoukhadar I; Higham CE; Kearney T; Colaco R; Gnanalingham K; Roncaroli F
Neuropathology; 2020 Jun; 40(3):261-267. PubMed ID: 31900996
[TBL] [Abstract] [Full Text] [Related]
19. Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment.
Pepe F; Pisapia P; Del Basso de Caro ML; Conticelli F; Malapelle U; Troncone G; Martinez JC
Histol Histopathol; 2020 Jul; 35(7):741-749. PubMed ID: 31872418
[TBL] [Abstract] [Full Text] [Related]
20. JAK-STAT inhibition impairs k-ras-driven lung adenocarcinoma progression.
Mohrherr J; Haber M; Breitenecker K; Aigner P; Moritsch S; Voronin V; Eferl R; Moriggl R; Stoiber D; Győrffy B; Brcic L; László V; Döme B; Moldvay J; Dezső K; Bilban M; Popper H; Moll HP; Casanova E
Int J Cancer; 2019 Dec; 145(12):3376-3388. PubMed ID: 31407334
[TBL] [Abstract] [Full Text] [Related]
[Next]
